Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × pemigatinib × Sarcoma × Clear all

Phase

Status

Not yet recruiting 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4 Other hematologic neoplasm 2 Tumor-Agnostic 1 Sarcoma 1 Other solid neoplasm 1 Lymphoid 1

Conditions

Interventions

Doxorubicin 28 Cyclophosphamide 22 pembrolizumab 21 Specimen Handling 20 Temozolomide 17 Surgical Procedures, Operative 15 Magnetic Resonance Spectroscopy 15 Gemcitabine 14 Biopsy 14 Blood Specimen Collection 13 Radiotherapy 12 fludarabine 11 atezolizumab 11 Ifosfamide 11 Vincristine 10 Trabectedin 8 Nivolumab 8 Irinotecan 8 Imatinib Mesylate 8 Drug Therapy 8 cabozantinib 7 X-Rays 7 Surveys and Questionnaires 7 liposomal doxorubicin 6 Radiation 6 selinexor 5 Sunitinib 5 Standard of Care 5 Radiation Dose Hypofractionation 5 Dactinomycin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06389799 2025-08-28

PERELI

Lund University Hospital

Phase 2 Recruiting

Liposarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡